Seven Cases of Gilles de la Tourette's Syndrome: Partial Relief with Clonazepam: A Pilot Study (Q39580941)

13 September 2017

Seven Cases of Gilles de la Tourette's Syndrome: Partial Relief with Clonazepam: A Pilot Study (English)

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

12 February 2023

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

12 February 2023

1 reference

M. Gonce

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A271517

12 February 2023

A. Barbeau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A271517

12 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=271517

12 February 2023

publication date

1 November 1977

1 reference

full work available at URL

13 September 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0317167100025129

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Canadian Journal of Neurological Sciences

12 February 2023

published in

1 reference

13 September 2017

4

1 reference

13 September 2017

279-283

1 reference

13 September 2017

4

1 reference

Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486

13 September 2017

1

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486

12 February 2023

2

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Gilles de la Tourette's disease: the report of a case and its treatment.

12 February 2023

6

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

A psychophysiological study of multiple tics.

12 February 2023

8

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Six cases of Gilles de la Tourette's syndrome

12 February 2023

11

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

A case with Gilles de la Tourette's syndrome: recurrent refractoriness to haloperidol, and unsuccessful treatment with L-dopa

12 February 2023

12

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.

12 February 2023

13

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

TOURETTE'S DISEASE: SYMPTOMATIC RELIEF WITH HALOPERIDOL

12 February 2023

14

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Treatment of Tourette's syndrome with haloperidol, review of 34 cases

12 February 2023

18

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Psychodynamic considerations in Gilles de la Tourette's disease, maladie des tics, with a report of 5 cases and discussion of the literature.

12 February 2023

19

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Clinical features of the Lesch-Nyhan syndrome

12 February 2023

21

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Letter: Self mutilation in Lesch-Nyhan syndrome

12 February 2023

23

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Familial occurrence of Gilles de la Tourette syndrome. Report of the syndrome occurring in a father and son

12 February 2023

24

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Multiple tic syndrome (Giles de la Tourette's syndrome)

12 February 2023

26

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Gilles de la Tourette's disease--a review

12 February 2023

27

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Differential diagnosis of Gilles de la Tourette's syndrome

12 February 2023

28

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

The symptomatology and diagnosis of Gilles de la Tourette's syndrome

12 February 2023

29

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Intention myoclonus: successful treatment with clonazepam

12 February 2023

31

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Manipulation of brain serotonin in the treatment of myoclonus

12 February 2023

32

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Altered 5-HT metabolism with clonazepam, diazepam and diphenylhydantoin

12 February 2023

33

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

The clinical picture and management of Gilles de la Tourette's syndrome

12 February 2023

34

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Familial incidence of Gilles de la Tourette's disease, with observations on aetiology and treatment.

12 February 2023

35

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Clonazepam. A review of a new anticonvulsant drug

12 February 2023

36

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

Tics and Gilles de la Tourette's syndrome: a follow-up study and critical review

12 February 2023

38

1 reference

https://api.crossref.org/works/10.1017/S0317167100025129

12 February 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=271517

12 February 2023

1 reference